Skip to main content
Clinical Trials/ITMCTR2000003617
ITMCTR2000003617
Not yet recruiting
Phase 1

A multicenter randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markers

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. It meets the diagnostic criteria of stage CKD2\-4 and stage 1\-2 of acute kidney injury;
  • 2\. Meet the criteria for TCM syndrome diagnosis of deficiency of spleen and kidney and mutual knot of toxin and blood stasis;
  • 3\. 24 hU \- pro 2\.5 grams or less;
  • 4\. Aged between 18 and 75;
  • 5\. Patients who voluntarily participate in this clinical trial and sign the informed consent.

Exclusion Criteria

  • 1\. pregnancy or preparation for pregnancy and breast\-feeding women;
  • 2\. complicated with serious primary diseases with other organs in urgent need of immediate treatment, or with malignant tumors, active tuberculosis and other consumption system diseases;
  • 3\. after renal transplantation;
  • 4\. mentally ill, unable to cooperate;
  • 5\. allergic to therapeutic drugs;
  • 6\. participants in other drug clinical trials or in other clinical trials within 3 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials